🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus real-world vs clinical trial efficacy — need advice Page 2

Rybelsus real-world vs clinical trial efficacy — need advice

julia.endo Thu, Nov 13, 2025 at 12:40 PM 9 replies 967 viewsPage 2 of 2
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Nov 13, 2025 at 3:30 PM#6

Wait there's going to be a 50mg oral version?? That would be a game changer honestly. I would switch in a heartbeat if the efficacy matched injectable.

Last edited: Nov 13, 2025 at 4:30 PM
37 12InsuranceTom, WendyG_ATL, SaraMom3 and 34 others
Reply Quote Save Share Report
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Nov 13, 2025 at 3:47 PM#7

For the travel issue specifically — a few tips that helped me keep using injectable while traveling constantly:

  • FRIO insulin cooling wallets — no refrigeration needed, just soak in water. Keeps pens cool for 48-72 hours.
  • TSA has NEVER given me an actual problem with my Wegovy pens. I keep them in a clear bag with the prescription label visible. Just tell them it's medication.
  • Most hotels will put medication in their kitchen fridge if you ask the front desk.
  • Wegovy pens are actually stable at room temperature (up to 86°F/30°C) for up to 28 days, so for short trips you might not even need refrigeration.
41 9marcus_mpls, DeniseRN_TPA, SandraNC_45 and 38 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Nov 13, 2025 at 4:04 PM#8

Ok this is all super helpful. It sounds like switching to oral at my current dose (1.7mg injectable) would be a downgrade in efficacy, and the daily fasting requirement might actually be MORE of a hassle than weekly injections.

I think I'll stick with injectable and try the FRIO wallet for travel. And keep my eye out for when/if the higher-dose oral formulation gets approved.

Thanks everyone — saved me from making a mistake! 🙏

19 3BrianDallas92, labquiet_amy, emily_PDX and 16 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Nov 13, 2025 at 4:21 PM#9

Smart decision. One more data point: the oral 50mg formulation from OASIS 1 also had higher rates of GI side effects compared to injectable 2.4mg in cross-trial comparisons. The 50mg pill delivers a LOT of semaglutide to the stomach lining even if only 1% is absorbed systemically, and that local GI exposure may cause more nausea/vomiting. Something to factor in if/when it becomes available.

— pharma_data_guy | PharmD | GLP-1 pharmacology nerd
1 18PharmHunterJen
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register